Drägerwerk AG & Co. KGaA

DB:DRW8 Stock Report

Market Cap: €848.9m

Drägerwerk KGaA Past Earnings Performance

Past criteria checks 2/6

Drägerwerk KGaA's earnings have been declining at an average annual rate of -10.4%, while the Medical Equipment industry saw earnings growing at 2% annually. Revenues have been growing at an average rate of 3.3% per year. Drägerwerk KGaA's return on equity is 7.1%, and it has net margins of 3%.

Key information

-10.4%

Earnings growth rate

-11.8%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate3.3%
Return on equity7.1%
Net Margin3.0%
Next Earnings Update25 Jul 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Drägerwerk KGaA makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:DRW8 Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 243,348100968323
31 Dec 233,374110963325
30 Sep 233,33994965339
30 Jun 233,27541973343
31 Mar 233,157-21983345
31 Dec 223,045-65981343
30 Sep 222,953-149982351
30 Jun 222,997-83968347
31 Mar 223,18625958339
31 Dec 213,328134938329
30 Sep 213,518224945311
30 Jun 213,611274930298
31 Mar 213,558278909294
31 Dec 203,406189912290
30 Sep 203,173171877278
30 Jun 202,97394869275
31 Mar 202,81929861268
31 Dec 192,78125848264
30 Sep 192,76548827255
30 Jun 192,71539816253
31 Mar 192,70144814253
31 Dec 182,59526797252
30 Sep 182,56416795255
30 Jun 182,57237791251
31 Mar 182,53346770241
31 Dec 172,57274770235
30 Sep 172,55673769227
30 Jun 172,52870767221
31 Mar 172,52674765221
31 Dec 162,52461768219
30 Sep 162,53048812220
30 Jun 162,54117831226
31 Mar 162,59615856229
31 Dec 152,60925868231
30 Sep 152,55346818232
30 Jun 152,54190797223
31 Mar 152,46785775218
31 Dec 142,43597750212
30 Sep 142,38394742206
30 Jun 142,34785732205
31 Mar 142,354101733203
31 Dec 132,374115745202
30 Sep 132,383113754203
30 Jun 132,401120756203

Quality Earnings: DRW8 has high quality earnings.

Growing Profit Margin: DRW8 became profitable in the past.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: DRW8's earnings have declined by 10.4% per year over the past 5 years.

Accelerating Growth: DRW8 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: DRW8 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-9.8%).


Return on Equity

High ROE: DRW8's Return on Equity (7.1%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.